Ameriprise Financial Inc Theravance Biopharma, Inc. Transaction History

Ameriprise Financial Inc

  • $364 Billion
  • Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 111,382 shares of TBPH stock, worth $902,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,382
Previous 111,772 0.35%
Holding current value
$902,194
Previous $1 Million 5.79%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$8.29 - $9.92 $3,233 - $3,868
-390 Reduced 0.35%
111,382 $944,000
Q1 2024

May 15, 2024
BUY
$8.22 - $11.59 $644,390 - $908,574
78,393 Added 234.86%
111,772 $1 Million
Q4 2023

Feb 14, 2024
BUY
$8.58 - $11.4 $286,391 - $380,520
33,379 New
33,379 $375,000
Q1 2023

May 15, 2023
BUY
$9.87 - $11.44 $5,921 - $6,864
600 Added 3.65%
17,030 $184,000
Q4 2022

Feb 14, 2023
BUY
$9.65 - $11.34 $158,549 - $186,316
16,430 New
16,430 $184,000
Q3 2021

Nov 15, 2021
SELL
$6.77 - $14.41 $76,568 - $162,977
-11,310 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$14.52 - $22.46 $59,836 - $92,557
-4,121 Reduced 26.71%
11,310 $164,000
Q1 2021

May 17, 2021
SELL
$16.57 - $21.08 $5.47 Million - $6.96 Million
-330,075 Reduced 95.53%
15,431 $315,000
Q4 2020

Feb 12, 2021
SELL
$14.89 - $20.16 $1.68 Million - $2.27 Million
-112,537 Reduced 24.57%
345,506 $6.14 Million
Q3 2020

Nov 16, 2020
SELL
$14.79 - $22.49 $15.5 Million - $23.5 Million
-1,044,830 Reduced 69.52%
458,043 $6.77 Million
Q2 2020

Aug 14, 2020
SELL
$20.64 - $30.69 $1.52 Million - $2.27 Million
-73,842 Reduced 4.68%
1,502,873 $31.5 Million
Q1 2020

May 15, 2020
BUY
$17.84 - $31.21 $21.9 Million - $38.3 Million
1,226,134 Added 349.74%
1,576,715 $36.4 Million
Q4 2019

Feb 14, 2020
SELL
$16.12 - $25.89 $1.12 Million - $1.79 Million
-69,186 Reduced 16.48%
350,581 $9.08 Million
Q3 2019

Nov 14, 2019
SELL
$16.51 - $23.78 $690,002 - $993,837
-41,793 Reduced 9.05%
419,767 $8.18 Million
Q2 2019

Aug 14, 2019
BUY
$15.6 - $25.15 $7.2 Million - $11.6 Million
461,560 New
461,560 $7.54 Million

Others Institutions Holding TBPH

# of Institutions
134
Shares Held
48.7M
Call Options Held
13.9K
Put Options Held
3.1K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $541M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email